Ousted Canopy co-founder Bruce Linton said he’s involved in a variety of different companies. While he’s an “activist investor (the good kind)” to Canadian LPs Slang Worldwide and DNA Genetics, he’s also senior advisor and/or director of Michigan dispensary company Gage Cannabis USA, an animal health-and-wellness CBD company called Better Choice, and at Toronto-based medical psychedelics provider Mind Medicine, which develops MDMA- and psilocybin-assisted treatments for mental illness.
- Linton said he believes psychedelics are about to become important medicine. “There’s probably untapped value, which will only go to the people who are at the beginning and bold.”
Ottawa Business Journal
- Canopy hopes to find a full-time CEO by the end of 2019 to replace both Linton and present acting CEO Mark Zekulin.
- Quebec convenience store giant Couche Tard hopes to become a “key player” in the cannabis sector, and hopes to enter the US legal-REC market through its Circle K stores.
- Seattle cannabis media portal Wikileaf will go public in Canada via reverse takeover, which we haven’t seen much of this year but was the shortest route to a public offering in the sector last year.